UnitedHealth Group

NYSE: UNH · Real-Time Price · USD
306.55
35.06 (12.91%)
At close: Aug 15, 2025, 3:10 PM

UnitedHealth Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
111.62B 109.58B 100.81B 99.18B 97.86B 98.78B 94.43B 92.36B 92.9B 91.93B 82.79B 80.89B 80.33B 80.15B 73.74B 72.34B 71.32B 70.2B
Cost of Revenue
91.6B 85.8B 79.5B 77.79B 76.8B 76.79B 72.42B 68.97B 70.02B 69.25B 61.91B 60.94B 60.69B 61.01B 56.16B 55.1B 54.21B 52.48B
Gross Profit
20.01B 23.77B 21.31B 21.39B 21.06B 21.99B 22B 23.39B 22.89B 22.68B 20.88B 19.95B 19.64B 19.14B 17.58B 17.23B 17.11B 17.72B
Operating Income
5.15B 9.12B 7.77B 8.71B 7.88B 7.93B 7.69B 8.53B 8.06B 8.09B 6.89B 7.46B 7.13B 6.95B 5.54B 5.71B 5.98B 6.74B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
4.08B 8.11B 6.79B 7.61B 5.67B 1M 6.86B 7.69B 7.23B 7.33B 6.21B 6.95B 6.67B 6.52B 5.11B 5.29B 5.57B 6.34B
Net Income
3.41B 6.29B 5.54B 6.05B 4.22B -1.41B 5.46B 5.84B 5.47B 5.61B 4.76B 5.26B 5.07B 5.03B 4.07B 4.09B 4.27B 4.86B
Selling & General & Admin
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
14.86B 14.65B 13.54B 12.68B 13.19B 14.06B 14.31B 14.86B 14.83B 14.6B 13.99B 12.49B 12.51B 12.19B 12.04B 11.52B 11.14B 10.98B
Operating Expenses
14.86B 14.65B 13.54B 12.68B 13.19B 14.06B 14.31B 14.86B 14.83B 14.6B 13.99B 12.49B 12.51B 12.19B 12.04B 11.52B 11.14B 10.98B
Interest Expense
1.03B 998M 1B 1.07B 985M 844M 830M 834M 828M 754M 676M 516M 467M 433M 431M 422M 410M 397M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
106.47B 100.46B 93.03B 90.47B 89.98B 90.85B 86.74B 83.83B 84.85B 83.84B 75.9B 73.43B 73.2B 73.2B 68.2B 66.63B 65.34B 63.46B
Income Tax Expense
510M 1.63B 1.01B 1.36B 1.24B 1.22B 1.18B 1.65B 1.57B 1.56B 1.31B 1.56B 1.47B 1.37B 919M 1.1B 1.2B 1.36B
Shares Outstanding (Basic)
910M 918M 927M 923M 921M 920M 924M 926M 930M 932M 934M 935M 935M 939M 941M 942M 943M 944M
Shares Outstanding (Diluted)
910M 918M 927M 930M 928M 922M 935M 936M 940M 943M 947M 948M 950M 954M 955M 955M 956M 957M
EPS (Basic)
3.74 6.91 5.98 6.56 4.58 -1.53 5.90 6.31 5.89 6.02 5.10 5.63 5.42 5.35 4.33 4.34 4.52 5.15
EPS (Diluted)
3.74 6.85 5.98 6.51 4.54 -1.53 5.83 6.24 5.82 5.95 5.03 5.55 5.34 5.27 4.26 4.28 4.46 5.08
EBITDA
7.22B 10.16B 8.84B 9.73B 7.67B 1.84B 8.66B 9.53B 9.08B 9.06B 7.87B 8.29B 7.93B 7.74B 6.31B 6.51B 6.76B 7.5B
EBIT
6.14B 9.1B 7.79B 8.69B 6.65B 845M 7.69B 8.53B 8.06B 8.09B 6.89B 7.46B 7.13B 6.95B 5.54B 5.71B 5.98B 6.74B
Depreciation & Amortization
1.08B 1.06B 1.04B 1.04B 1.02B 997M 974M 1.01B 1.02B 970M 982M 828M 802M 788M 771M 796M 778M 758M